Research output per year
Research output per year
Personal profile
In Korean
김석호 교수(의과대학 의학과)
Education
o (1993) B.A., Chungnam National University, Daejeon
o (1995) M.A., Chungnam National University, Daejeon
o (2004) Ph.D., Chungnam National University, Daejeon
o (1995) M.A., Chungnam National University, Daejeon
o (2004) Ph.D., Chungnam National University, Daejeon
Professional Experience
o (2022~Present) Assistant Professor, Kyungpook National University, Daegu
o (2014~2022) Assistant, Kyungpook National University, Daegu
o (2012~2014) Regulatory Scientist, Ministry of Food & Drug Safety, Osong
o (1996~2007) Health Scientist, National Institute of Health, Osong
o (1995~1996) Researcher, Korea Research Institute of Bioscience & Biotechnology, Daejeon
o (2014~2022) Assistant, Kyungpook National University, Daegu
o (2012~2014) Regulatory Scientist, Ministry of Food & Drug Safety, Osong
o (1996~2007) Health Scientist, National Institute of Health, Osong
o (1995~1996) Researcher, Korea Research Institute of Bioscience & Biotechnology, Daejeon
Research Interests
Pathogenic bacteria, bacterial drug resistance, Molecular epidemiology, antimicrobial agents, bacteriophages, endolysins
Major Research Achievements
o First Report of Plasmid-Mediated Macrolide-Clindamycin -Tetracycline Resistance in a High Virulent Isolate of Cutibacterium acnes ST115
o Development of a Magnetic Bead-Based Method for Specific Detection of Enterococcus faecalis Using C-Terminal Domain of ECP3 Phage Endolysin
o Genomic and Phenotypic Characterization of Cutibacterium acnes Bacteriophages Isolated from Acne Patients
o LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity
o Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
o Development of a Magnetic Bead-Based Method for Specific Detection of Enterococcus faecalis Using C-Terminal Domain of ECP3 Phage Endolysin
o Genomic and Phenotypic Characterization of Cutibacterium acnes Bacteriophages Isolated from Acne Patients
o LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity
o Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
My gallery
×
![]()
Fingerprint
Dive into the research topics where Shukho Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Characterization and genome analyses of the novel phages targeting extraintestinal Escherichia coli clones ST131 and ST410
Shamsuzzaman, M., Choi, Y. J., Kim, S. & Kim, J., Oct 2025, In: International Microbiology. 28, 7, p. 2233-2245 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Evaluation of Bacteriophage and Antibiotic Synergy Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
Kim, B., Kim, S., Choi, Y. J., Shin, M. & Kim, J., Jun 2025, In: Journal of Bacteriology and Virology. 55, 2, p. 131-141 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Segatella intestinalis sp. nov., and Parabacteroides caeci sp. nov., novel potential probiotics from the human gut microbiome
Shamsuzzaman, M., Dahal, R. H., Choi, Y. J., Kim, S. & Kim, J., Sep 2025, In: Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology. 118, 9, 136.Research output: Contribution to journal › Article › peer-review
-
A Novel Truncated CHAP Modular Endolysin, CHAPSAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection
Choi, Y. J., Kim, S., Dahal, R. H. & Kim, J., 1 Aug 2024, In: Journal of Microbiology and Biotechnology. 34, 8, p. 1718-1726 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Bacteriophage as a novel therapeutic approach for killing multidrug-resistant Escherichia coli ST131 clone
Shamsuzzaman, M., Kim, S. & Kim, J., 2024, In: Frontiers in Microbiology. 15, 1455710.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations